According to Motilal Oswal Securities, Dr Reddys Laboratories is expected to report subdued numbers in Q1FY17, with flat revenue growth and profit after tax (PAT) at Rs 500 crore, down 20% year-on-year (YoY) http://goo.gl/UhjSUA
http://goo.gl/UhjSUA
Tuesday, 26 July 2016
According to Motilal Oswal Securities, Dr Reddys Laboratories is expected to report subdued numbers in Q1FY17, with flat revenue growth and profit after tax (PAT) at Rs 500 crore, down 20% year-on-year (YoY) http://goo.gl/UhjSUA
According to Motilal Oswal Securities, Dr Reddys Laboratories is expected to report subdued numbers in Q1FY17, with flat revenue growth and profit after tax (PAT) at Rs 500 crore, down 20% year-on-year (YoY) http://goo.gl/UhjSUA
http://goo.gl/UhjSUA
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment